Clinical Trial Update: Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of ICM with or without AZD2281 (olaparib) in patients with advanced pancreatic cancer; the study is completed and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ICM
• Olaparib (Olaparib)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED | Results posted: 2016-03-22